From: Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
Cancer type | Aim of study |
---|---|
Breast | - Elucidate pathways of tumorigenesis and metastasis |
- Detect drug response of organoids | |
- Validation of disease-causing genomic variations | |
- Organoid biobank | |
Colorectal | - Genetic diversity of patient- derived tumor organoids and the original tumor biopsy |
- Organoid biobank | |
- Personalized medicine | |
- Modeling specific subtype of colon cancer | |
Endometrium | - Organoid biobank |
- Precision medicine | |
Glioblastoma | - Organoid model of non-epithelial tumor |
Liver | - Organoid biobank |
- Detection of driver mutations | |
Pancreatic | - Pancreatic ductal adenocarcinoma modeling and drug screening |
- Organoid model | |
Prostate | - Tumor modeling |
- Lineage and cell transition monitoring | |
Renal | Method for renal carcinoma 3D culture |
Stomach and esophageal | - Genomic-based classification of gastric cancer |
- New driver mutation detection | |
- Personalized medicine | |
- Organoid biobank | |
- Long-term 3D cultures of human gastric stem cells and bacterial infection study |